Atea

+$0.63 (+8.27%) Today
$0.00 (0.00%) As of 9:40 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Atea and other ETFs, options, and stocks.

About AVIR

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae.

CEO
Jean-Pierre Sommadossi
Employees
59
Headquarters
Boston, Massachusetts
Founded
2012

AVIR Key Statistics

Market cap
681.50M
Price-Earnings ratio
14.64
Dividend yield
—
Average volume
781.43K
High today
$8.30
Low today
$7.56
Open price
$7.60
Volume
767.75K
52 Week high
$46.91
52 Week low
$5.31

AVIR Earnings

-$1.74
-$0.71
$0.31
$1.34
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure